Introduction
While the ultimate fate of the majority of ovarian follicles is atretic degeneration (Byskov, 1978) , factors which regulate atresia are poorly understood. Ovarian steroids may alter the folliculogenic processes and, in doing so, alter the rate of atresia (Goodman & Hodgen, 1983) . Androgens have been reported to be inhibitory (Louvet et ai, 1975; Farookhi, 1980; Bagnell et ai, 1982) or stimu¬ latory (Hillier & Ross, 1979) to follicular development; the action appears to depend on the androgen used and the dosage and duration of treatment. Dihydrotestosterone (DHT) specifically inhibits the FSH induction of LH receptors in granulosa cells (Farookhi, 1980; Jia et ai, 1985) , possibly leading to follicular atresia if the follicles fail to ovulate. On the other hand, oestradiol, when administered to PMSG-primed hypophysectomized immature rats, amplifies the responsive¬ ness of ovarian follicles to gonadotrophic stimulation (Richards, 1979) . Oestradiol has also been reported to increase ovarian weight and to decrease the rate of atresia (Harman et ai, 1975 A previous publication from this laboratory reported that DHT treatment of hypophysectomized immature rats was marked by inhibition of both follicular growth and ovulation (Bagnell et ai, 1982) . These results have been challenged (Kohut et ai, 1985) , and the following study was under¬ taken: (1) to confirm that DHT inhibits follicle growth, (2) to show that DHT affects the develop¬ ment not only of large follicles but also of follicles of other sizes, and (3) Byskov (1978) . Every section was examined and follicles were counted and classified only in the cross-section which included the germinal vesicle to avoid duplicate counting.
Radioimmunoassay of gonadotrophins. Blood was allowed to clot and the resulting serum frozen for gonado¬ trophin assay. Concentrations of serum LH and FSH were determined by the double-antibody RIA method as described by O'Connor et ai (1982) and Rao& Mahesh(1986 Roy & Greenwald (1985) required about 6 h to collect follicles while a similar number of follicles could be obtained in approximately 30 min using the Percoli gradient and Teflon sieves. Because the follicles were isolated quickly, the viability of the granulosa cells in the follicles remained high.
Oestrogen assay. Follicles in each group were suspended in 1 ml water and homogenized with an all-glass homogenizer. The steroids were extracted with ether and the oestrogen content determined by specific radioimmuno¬ assay as previously described by Meiner & Abney (1980) using the TG E2K antibody obtained from Professor Delwood Collins of Emory University, Atlanta, Georgia, USA. The intra-and interassay coefficients of variation for this assay were 6-3% and 11-4%, respectively.
Granulosa cell isolation. In some studies, the granulosa cells were harvested from the isolated follicles using a modification of the method of Campbell (1979) . In this procedure, isolated follicles were covered with McCoy's 5A buffer containing 6-8 mM-EGTA and 0-2% BSA and incubated for 10 min at 37°C in a 95% 02-5% C02 atmosphere. The follicle suspension was centrifuged at 65 g for 5 min, the supernatant discarded and the resulting pellet covered with McCoys 5A with 0-5 M-sucrose and 1-8 mM-EGTA and incubated for an additional 5 min. 
Results

Animal studies
When rats were injected with doses of DHT ranging from 0-25 to 20 mg/kg body weight, the percentage of rats that ovulated and the number of ova shed was reduced significantly only at the dose of 10 mg/kg (Table 1) . Accordingly, rats received 1 mg DHT/kg in 4 daily doses in all subsequent studies. DHT had little effect on the number of follicles present in the ovaries. Figure 1 shows that, in serial cross-sections of ovaries from DHT-treated and control rats, there was no significant differ¬ ence between the number of healthy follicles at all stages of development. However, the number of atretic follicles in the DHT-treated animals was elevated over the number present in ovaries of control rats. Fig. 1 Fig. 2(a) show a slight difference in the LH pattern between DHT-injected and control animals although analysis of variance proves that the patterns are not different. The patterns of FSH release (Fig. 2b) were identical in the two treatment groups. Table 2 shows that the administration of 1 mg/kg dose of oestradiol had no effect on the per¬ centage of rats ovulating or on the number of ova shed per rat. However, when co-administered with DHT, oestradiol completely prevented the androgen inhibition of ovulation.
The next series of studies demonstrated that the inhibitory effect of DHT was not limited only to the large, preovulatory follicles which ovulate at 72 h after PMSG. Figure 3 shows that the number of ovulations per rat from DHT-treated animals was significantly reduced compared to control rats in the treatment cycle (Cycle 1: 36 h after the last DHT injection), in the PMSGinduced intermediate cycle (84 h after the last DHT injection), and in the next subsequent cycle (Cycle 2: 142 h after the last DHT treatment).
Isolated follicle studies
Using a modification of the follicle isolation procedure of Roy & Greenwald (1985) combined with the Percoli gradient centrifugation and Teflon sieve filtration, large numbers of follicles were separated. Before the gradient centrifugation and filtration steps, the digestate contained a collection of follicles of all sizes plus ovarian debris and free granulosa cells (Fig. 4a) . The steps in the purification yielded follicles with diameters of < 200 µ , 200-400 µ and > 400 µ which were largely free of debris and granulosa cell contamination (Figs 4b-4d) .
Figure 5(a) shows that DHT did not affect the total number of follicles which could be isolated in each size. These results also show that the total number of follicles/ovary obtained from the isolation procedure was between 150 and 200. However, despite the similar number of follicles in the treatment groups, the number of granulosa cells which could be isolated was reduced by the androgen treatment in the isolated follicles of all 3 sizes (Fig. 5b) . However, DHT did not alter the viability of the existing granulosa cells; viability was generally nearly 60% or greater.
Dihydrotestosterone treatment significantly reduced the oestrogen content of the follicles. When equal numbers of follicles from DHT-treated and control animals were analysed for oestra¬ diol concentration, the follicles of >400 µ and 200-400 µ from the DHT-treated rats contained less oestradiol than did follicles from the control animals (Fig. 5c) . Furthermore, DHT treatment caused a significant reduction in aromatase activity in granulosa cells from all sizes of follicles (Fig. 5d) .
Discussion
Conflicting reports exist in the literature as to the effects of androgens on follicular growth and development. Some investigators have used hypophysectomized, oestrogen-treated animals and reported a stimulation of ovarian growth or function with androgens (Hillier & Ross, 1979) . Others have found an inhibition with androgen treatment (Louvet et ai, 1975) or no effect of androgens (Kohut et ai, 1985) . Previously, we showed that DHT inhibited ovulation in PMSG-primed hypo¬ physectomized immature female rats (Bagnell et ai, 1982) ; however, this observation was not con¬ firmed in a subsequent study (Kohut et ai, 1985) . It is not possible to discern why Kohut et ai (1985) were not able to repeat our results although we feel that the type of PMSG used is of critical importance. Batches of PMSG may vary in their relative LH and FSH activities. To confirm the importance of the type of PMSG used and to validate our previous findings (Bagnell et ai, 1982) , several PMSG preparations were tested for their ability to stimulate follicular growth in hypophy¬ sectomized, immature rats. The ovarian responses proved to be quite variable between and even within the various batches of PMSG (unpublished data). Therefore, the use of the PMSG-treated, hypophysectomized rat model was discontinued. In the present studies which utilized intact PMSG-primed, immature female rats, the response to PMSG was uniform and repeatable.
The results in Table 1 sh *w that, at a dose of 1 mg DHT/kg, the ovulation rate is significantly reduced while at 2 mg DHT/kg, the reduction is not statistically significant. The underlying basis for this biphasic effect is not apparent although we previously reported that in the ovarian follicle population of PMSG-treated hypophysectomized, immature rats, treatment with 1 mg DHT/kg significantly inhibited growth of secondary and tertiary follicles while 2 mg DHT/kg failed to block follicle development (Bagnell et ai, 1982; Mahesh et ai, 1987) . Bagnell et ai (1982) reported that, in DHT-treated, hypophysectomized rat ovaries, the number of atretic secondary follicles increased with a concurrent rise in the number of primary follicles. Co-treatment with oestrogen prevented the decrease in the ovulation rate and the histological profile of the androgen plus oestrogentreated rats was similar to that of the controls. These experiments therefore demonstrated that DHT caused an increase in atresia among secondary follicles and that oestrogen reversed the detrimental effects of the androgen.
The action of DHT to decrease the ovulation rate could be caused either by the androgen acting on the pituitary to suppress the gonadotrophin surge or via a direct action on the ovaries. We have determined (unpublished) that, after a single subcutaneous injection of DHT, blood concentrations were maximal at 1 h but the androgen was cleared from the blood by 6 h. It therefore seems unlikely that DHT is acting directly on the pituitary since the androgen is cleared in less than 6 h and the gonadotrophin surge starts nearly 20 h after the last injection. Furthermore, appropriate statistical analysis of the circulating concentrations of LH and FSH in the DHT-treated and control rats showed that the androgen has no effect on the pattern of secretion of either gonadotrophin (Figs 2a, 2b) . Rather, it must be concluded that the androgen is acting directly on the follicles. The idea of a direct steroid effect is further supported by the observation that, when oestrogen is co-administered with DHT (Table 2) , the expected decrease in the number of ovulations failed to occur. Other investigators (Payne & Hellbaum, 1955; McNatty et ai, 1979; Richards & Kersey, 1979; Braw et ai, 1981) have likewise concluded that adequate oestrogen production is essential to follicular development.
Two theories exist as to the vulnerability of follicles in their growth and development. Byskov (1974 Byskov ( , 1979 and Ryan (1981) have claimed that atresia is random, can ensue at any time and is not specific to any stage of follicular development. Other investigators (Richards & Midgley, 1976; Richards et ai, 1978; Hirshfield & Midgley, 1978a; Hirshfield & Schmidt, 1987) point to a specific period of vulnerability during which follicles may become atretic. Butcher & Kirkpatrick-Keller (1984) demonstrated that, in cyclic rats, atresia does not occur randomly and is uncommon in follicles < 100 µ or > 400 µ but occurs predominantly in follicles 100-400 µ in diameter. Similarly, Hirshfield (1988) reported that the greatest rate of atresia was in follicles 300-350 µ in cyclic rats. In follicles induced to grow with diethylstilboestrol in hypophysectomized rats, atresia was often greater than 50% in follicles 200-400 µ in diameter (Sadrkhanloo et ai, 1987) . It is from these intermediate size follicles that ovulatory follicles in the next cycle are selected (Hirshfield & Midgley, 1978b; Hirshfield, 1981; Hirshfield, 1984) . In the present studies, ovulation rates in cycles subsequent to the treatment cycle were examined to determine whether DHT affects all follicle sizes. It was reasoned that follicles which ovulate in subsequent cycles have advanced from follicles that were 200-400 µ in size during the treatment (first) cycle. Furthermore, the surge of LH during the first cycle (52-60 h after PMSG) would trigger ovulation of the large follicles while the accompanying surge of FSH would recruit smaller follicles to grow (Schwartz, 1974) and ovulate in the next cycle (Hirshfield & Midgley, 1978b; Hirshfield, 1983) . In the present study, when the androgen was given for 36 h after PMSG treatment, large preovulatory follicles were the most affected in Cycle 1. However, smaller follicles (200-400 µ ) which would ovulate in later cycles were also affected since ovulation rates in the subsequent cycles were reduced as well (Fig. 3) . This suggests that a period of androgen sensitivity exists and that period may encompass a wider range of follicular sizes than has been previously considered.
Although the present method of follicle isolation is rapid, it had to be established that the number of isolated follicles accurately reflects the number present in the ovary. When the ovaries of PMSG-and DHT-treated or control rats were analysed histologically, about 160-180 follicles were present per ovary with about 50% classed as primary, 32% secondary, 6% tertiary and 12-25% atretic (Fig. 1) . If the primary, secondary and tertiary follicles roughly correspond to follicles of size ranges <200 µ , 200-400 µ and >400 µ , then there is good agreement between the histologi¬ cal method and isolation method for assessing the size of the follicle population (Fig. 5a) . Any discrepancies between the estimates from the two methods may lie in the failure of the isolation method to distinguish between atretic and healthy follicles. Our findings of 160-180 follicles per ovary generally agree with Hirshfield (1988) but fall below the estimates of 250-300 follicles per ovary by Butcher & Kirkpatrick-Keller (1984) .
In the present studies, fewer granulosa cells were found per follicle in ovaries from DHT-treated animals than from control animals. This reduction in granulosa cell numbers per follicle without a reduction in total number of follicles means that DHT treatment may reduce the rate at which granulosa cells proliferate. Using autoradiographic techniques, Hirshfield & Schmidt (1987) have shown that healthy follicles of a known size contain a predictable number of granulosa cells and that atresia is accompanied by reduced numbers of granulosa cells per follicle. In the present exper¬ iments, the number of granulosa cells in the ovaries of the DHT-treated rats may have fallen below the minimum number required to prevent atresia so the follicles fail to ovulate in response to the LH surge.
In the studies presented herein, granulosa cells from follicles < 200 µ synthesized significant amounts of oestradiol when incubated with testosterone and an NADPH-generating system. Roy & Greenwald (1987) likewise reported that even the smallest follicles with few granulosa cells and no thecal cells made some steroids including oestrogens provided that the appropriate substrate was supplied. Figure 5(d) shows that DHT treatment reduces the oestrogen producing abilities of the granulosa cells of all follicle sizes, including those < 200 µ , by suppression of aromatase activity. Our findings that DHT inhibits aromatase activity seem to be at odds with those of Daniel & Armstrong (1980) who reported DHT enhancement of the enzyme activity. These authors based their findings on granulosa cells from untreated immature rats cultured with FSH with and without DHT. Such granulosa cells may not be comparable to the cells from the immature rats treated in vivo with PMSG and DHT (Fig. 5d) . By injecting PMSG into the animals, the granulosa cells are exposed not only to FSH and some LH stimulation, but also to a variety of paracrine regulatory factors from adjacent thecal cells or carried in the blood stream. Also of interest in this respect is the publication of Harlow et ai (1988) in which DHT enhanced aromatase in granulosa cells isolated from small follicles of the marmoset ovary but the androgen was inhibitory for the cells from large follicles. The authors interpret this to mean that, in more differentiated granulosa cells, DHT is inhibitory while in less differentiated cells the androgen is stimulatory. PMSG stimulation of immature rats may lead to some differentiation in the granulosa cells of all sizes of follicles and may make them sensitive to the inhibitory actions of DHT (Fig. 5d) .
From these studies, we conclude that the decrease in ovulation rate in DHT-treated 
